Brandywine Global Investment Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-142,524
| Closed | -$22.4M | – | 612 |
|
|
2025
Q3 | $22.4M | Sell |
142,524
-10
| -0% | -$1.54K | 0.15% | 149 |
|
|
2025
Q2 | $23.9M | Sell |
142,534
-3,639
| -2% | -$540K | 0.17% | 147 |
|
|
2025
Q1 | $20.1M | Sell |
146,173
-1,410
| -1% | -$180K | 0.15% | 161 |
|
|
2024
Q4 | $17.5M | Sell |
147,583
-10,755
| -7% | -$1.26M | 0.13% | 176 |
|
|
2024
Q3 | $17.7M | Buy |
158,338
+15,117
| +11% | +$1.58M | 0.12% | 179 |
|
|
2024
Q2 | $14.1M | Buy |
143,221
+8,796
| +7% | +$896K | 0.11% | 195 |
|
|
2024
Q1 | $15M | Sell |
134,425
-500
| -0.4% | -$53.9K | 0.11% | 188 |
|
|
2023
Q4 | $13.6M | Sell |
134,925
-6,314
| -4% | -$626K | 0.11% | 198 |
|
|
2023
Q3 | $12.3M | Sell |
141,239
-8,039
| -5% | -$727K | 0.11% | 198 |
|
|
2023
Q2 | $14.1M | Sell |
149,278
-14,582
| -9% | -$1.23M | 0.12% | 183 |
|
|
2023
Q1 | $12.4M | Buy |
163,860
+12,938
| +9% | +$976K | 0.1% | 191 |
|
|
2022
Q4 | $11.6M | Sell |
150,922
-5,164
| -3% | -$392K | 0.09% | 207 |
|
|
2022
Q3 | $10.4M | Sell |
156,086
-3,021
| -2% | -$191K | 0.1% | 192 |
|
|
2022
Q2 | $8.32M | Buy |
159,107
+57,037
| +56% | +$3.24M | 0.07% | 243 |
|
|
2022
Q1 | $5.79M | Buy |
+102,070
| New | +$5.47M | 0.04% | 363 |
|
|
2021
Q1 | – | Sell |
-246,086
| Closed | -$13.2M | – | 675 |
|
|
2020
Q4 | $13.2M | Sell |
246,086
-1,223
| -0.5% | -$63.5K | 0.11% | 199 |
|
|
2020
Q3 | $11.6M | Sell |
247,309
-8,726
| -3% | -$448K | 0.11% | 175 |
|
|
2020
Q2 | $13.4M | Sell |
256,035
-2,706
| -1% | -$139K | 0.14% | 155 |
|
|
2020
Q1 | $12.4M | Sell |
258,741
-1,500
| -0.6% | -$77.9K | 0.15% | 143 |
|
|
2019
Q4 | $13M | Sell |
260,241
-36,080
| -12% | -$1.86M | 0.09% | 192 |
|
|
2019
Q3 | $14M | Buy |
296,321
+172,183
| +139% | +$7.86M | 0.1% | 178 |
|
|
2019
Q2 | $5.85M | Buy |
+124,138
| New | +$5.73M | 0.04% | 371 |
|
|
2017
Q4 | – | Sell |
-43,074
| Closed | -$2.88M | – | 890 |
|
|
2017
Q3 | $2.88M | Sell |
43,074
-1,157
| -3% | -$81.8K | 0.02% | 522 |
|
|
2017
Q2 | $3.45M | Sell |
44,231
-238,404
| -84% | -$18M | 0.02% | 514 |
|
|
2017
Q1 | $23M | Buy |
+282,635
| New | +$22.2M | 0.15% | 132 |
|
|
2016
Q4 | – | Sell |
-281,349
| Closed | -$21.9M | – | 938 |
|
|
2016
Q3 | $21.9M | Buy |
281,349
+96,979
| +53% | +$7.84M | 0.14% | 130 |
|
|
2016
Q2 | $14.4M | Buy |
+184,370
| New | +$14.7M | 0.1% | 181 |
|
|
2015
Q4 | – | Sell |
-129
| Closed | -$10K | – | 944 |
|
|
2015
Q3 | $10K | Buy |
+129
| New | +$10.8K | ﹤0.01% | 908 |
|
|
2015
Q2 | – | Sell |
-140
| Closed | -$13K | – | 990 |
|
|
2015
Q1 | $13K | Hold |
140
| – | – | ﹤0.01% | 909 |
|
|
2014
Q4 | $12K | Sell |
140
-227,182
| -100% | -$17.9M | ﹤0.01% | 921 |
|
|
2014
Q3 | $17M | Buy |
227,322
+40,170
| +21% | +$2.92M | 0.13% | 144 |
|
|
2014
Q2 | $12.8M | Buy |
187,152
+25,800
| +16% | +$1.76M | 0.1% | 168 |
|
|
2014
Q1 | $11.3M | Sell |
161,352
-740
| -0.5% | -$51.5K | 0.1% | 184 |
|
|
2013
Q4 | $10.8M | Buy |
162,092
+1,890
| +1% | +$116K | 0.1% | 180 |
|
|
2013
Q3 | $8.36M | Buy |
160,202
+15,282
| +11% | +$776K | 0.08% | 223 |
|
|
2013
Q2 | $6.84M | Buy |
+144,920
| New | +$6.62M | 0.07% | 265 |
|
Other funds holding CAH
Brandywine Global Investment Management's CAH Position: Q4 2025 in Review
Brandywine Global Investment Management sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 142,524 shares — an estimated $22.4M sold.
Brandywine Global Investment Management first reported a position in CAH in Q2 2013 and held it in 36 quarters. The position peaked at $23.9M in Q2 2025. 1,412 funds tracked by Wall St. Rank hold CAH as of Q4 2025.
- Brandywine Global Investment Management reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
- Brandywine Global Investment Management sold 142,524 Cardinal Health shares in Q4 2025, an estimated $22.4M.
- Brandywine Global Investment Management first reported a position in Cardinal Health in Q2 2013 and held it in 36 quarters.
- Brandywine Global Investment Management's Cardinal Health position peaked at $23.9M in Q2 2025.
- 1,412 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.